Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRM1 | P35372 | 8/20 | 0.49 |
| ▸ | OPRL1 | P41146 | 7/20 | 0.49 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.49 |
| ▸ | HTR2A | P28223 | 2/20 | 0.47 |
| ▸ | SLC6A9 | P48067 | 1/20 | 0.42 |
| ▸ | USP2 | O75604 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.40 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.40 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.39 |
| ▸ | SSTR4 | P31391 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3713554 | 0.84 | OPRM1 (0.37) | OPRM1OPRL1OPRK1HTR2ASLC6A9 | |
| SCHEMBL3718210 | 0.83 | DRD2 (0.42) | OPRK1HTR2A | |
| SCHEMBL3712760 | 0.83 | SLC6A3 (0.41) | OPRM1OPRL1OPRK1SLC6A9CYP2D6 | |
| SCHEMBL3715627 | 0.81 | HTR2A (0.43) | OPRM1OPRL1OPRK1HTR2ASLC6A9 | |
| SCHEMBL3707150 | 0.81 | SLC6A3 (0.47) | — | |
| SCHEMBL3705030 | 0.81 | SLC6A4 (0.47) | OPRM1OPRL1SLC6A9USP2ALDH1A1 | |
| SCHEMBL3707873 | 0.81 | CHRNA1 (0.37) | OPRM1OPRL1OPRK1HTR2ASLC6A9 | |
| SCHEMBL294971 | 0.81 | OPRM1 (0.63) | OPRM1OPRL1OPRK1 | |
| SCHEMBL294583 | 0.81 | OPRM1 (0.63) | OPRM1OPRL1OPRK1 | |
| SCHEMBL3718146 | 0.80 | OPRM1 (0.49) | OPRM1OPRL1SLC6A9ALDH1A1SIGMAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2391603-A1 | AROYLAMINO - AND HETEROAROYLAMINO-SUBSTITUTED PIPERIDINES AS GLYT-1 INHIBITORS | F. Hoffmann-La Roche AG (CH) | 2011-12-07 | — | — | EP | disclosed |
| WO-2010086251-A1 | AROYLAMINO - AND HETEROAROYLAMINO-SUBSTITUTED PIPERIDINES AS GLYT-1 INHIBITORS | F. HOFFMANN-LA ROCHE AG (CH) | 2010-08-05 | — | — | WO | disclosed |